Product Images Xelstrym
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 24 images provide visual information about the product associated with Xelstrym NDC 68968-0220 by Noven Therapeutics, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
chemical structure - xelstrym 01
Figure1 - xelstrym 02
figure2 - xelstrym 03
figure3 - xelstrym 04
This appears to be a table of data related to a study of a medication's effects on different populations. It includes information on age ranges (65-74 and greater than or equal to 75), gender, and different levels of renal impairment. There are also measurements provided for PK (pharmacokinetics) including Cmax and AUC, as well as fold change and 90% CI. However, without additional context it is not possible to know the specific medication or implications of these findings.*
figure4 - xelstrym 05
This text appears to be a list of drugs and their interaction with certain enzymes in the body. Guanfacine and Venlafaxine are interacting drugs, and other drugs such as Caffeine, Dextromethorphan, Omeprazole, and Midazolam are substrates for different enzymes (CYP1A2, CYP2D6, CYP2C19, and CYP3A). There is also information on "Fold Change" and "90% CI," but without additional context, it's not clear what those mean.*
figure5 - xelstrym 06
figure6 - xelstrym 07
Not available.*
Figure A (not to scale). - xelstrym 08
Figure A (not to scale). - xelstrym 09
The text is prompting the user to select one application site, which can be either the upper arm or the upper back.*
Figure A (not to scale). - xelstrym 10
Figure A (not to scale). - xelstrym 11
Figure A (not to scale). - xelstrym 12
Figure A (not to scale). - xelstrym 13
Figure A (not to scale). - xelstrym 14
Figure A (not to scale). - xelstrym 15
Figure A (not to scale). - xelstrym 16
Figure A (not to scale). - xelstrym 17
Figure A (not to scale). - xelstrym 18
Figure A (not to scale). - xelstrym 19
Figure A (not to scale). - xelstrym 20
Carton Label - 4.5 mg - xelstrym 21
Before using XELSTRYM, please read the Instructions for Use to learn how to apply, remove and dispose of the patch. The text below appears not to be relevant as it contains gibberish. The XELSTRYM is a transdermal system for Dextroamphetamine with a 4.5mg dosage for transdermal use only, available in a pack of 30 transdermal systems.*
Outer Carton Label - 9.0 mg - xelstrym 22
Before using XELSTRYM, refer to the Instructions for Use for guidance on how to apply, remove, and dispose of the patch. For additional details about the medication, consult the enclosed Medication Guide and Prescribing Information. The rest of the text is not available.*
Outer Carton Label - 13.5 mg - xelstrym 23
Xelstrym™ is a transdermal system containing 13.5 mg/9 hours of dextroamphetamine used for transdermal use only. The instruction manual must be read first before utilizing Xelstrym to learn how to apply, remove, and dispose of patches. The remaining text is not readable.*
Outer Carton Label - 18.0 mg - xelstrym 24
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.